Skip to main content
Clinical Trials/NCT02390791
NCT02390791
Completed
N/A

Developing New Technologies to Improve ADHD Medication Continuity

Children's Hospital Medical Center, Cincinnati1 site in 1 country85 target enrollmentSeptember 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Attention Deficit Hyperactivity Disorder
Sponsor
Children's Hospital Medical Center, Cincinnati
Enrollment
85
Locations
1
Primary Endpoint
Medication Continuity: The Number of Days Covered With Medicine
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Cluster randomized controlled trial to evaluate the general effectiveness of intervention compared to control on medication continuity as measured by prescriptions written and other more proximal outcomes during the first six months of treatment.

Detailed Description

This cluster randomized controlled trial will evaluate the general effectiveness of the intervention (e.g. enhanced myADHDportal.com), compared to control (e.g. treatment as usual standard portal), on medication continuity as measured by prescriptions written and other more proximal outcomes during the first six months of treatment.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
August 2017
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Parents of children are eligible to participate if
  • their child receives ADHD care at one of the pediatric primary care practices that is partnering to conduct this trial
  • child being registered on myADHDportal.com to initiate child assessment of ADHD
  • child age 6-10 years
  • child must not have been previously treated with ADHD medication
  • child prescribed ADHD medication within 12 months of enrolling in the study

Exclusion Criteria

  • Unable to read and speak English

Outcomes

Primary Outcomes

Medication Continuity: The Number of Days Covered With Medicine

Time Frame: first 6 months of treatment

the number of days covered with medicine will be calculated from audit of prescriptions written

Secondary Outcomes

  • Parent-reported Necessity to Concerns Differential (Beliefs About Medication Scale)(6 months after starting treatment)
  • Parent-reported Decisional Conflict (Decisional Conflict Scale)(6 months after starting treatment)
  • Parent Trust in Provider (Trust in Provider Scale)(6 months after starting treatment)
  • Working Alliance Inventory(6 months after starting treatment)
  • Parent Perceived Social Support (Perceived Social Support Scale)(6 months after starting treatment)
  • Parent Distress (Parenting Stress Index - Short Form)(6 months after starting treatment)
  • Number of Participants With Side Effects Rated by Parents as Moderate or Severe on the Pittsburgh Side Effects Rating Scale(6 months after starting treatment)
  • Total Number of myADHDportal.Com Log-ins by Parent(6 months after starting treatment)
  • Total Number of Measures Completed by Parents to Track Child Response to Treatment(6 months after starting treatment)

Study Sites (1)

Loading locations...

Similar Trials